←
Brian J. Abraham45 posts
Brian J. Abraham avatar

Brian J. Abraham

@TheAbraLab

Computational Biologist studying how genes are controlled in healthy and diseased cells

◷ Joined June 2014▧ 13 Photos and videos
Brian J. Abraham avatar
Brian J. Abraham@TheAbraLab·21 Apr 2023

I don't know that I've seen a project that ended so far and so much more important than the OG plan. From feelings that something is weird about CDK13 to battling the lack of reagents to separate it from CDK12 to tying stumbling polymerases to cancers. Big work; long time coming.

Normally, cells make gene expression mistakes, but luckily CDK13 triggers clean-up of “junk” RNAs from protein coding genes. We found that when CDK13 is mutated, these “junk” RNAs accumulate, driving more aggressive melanoma. Turns out, it is important to shred the trash!

Post attachment
Brian J. Abraham avatar
Brian J. Abraham@TheAbraLab·8 Nov 2022

St. Jude is seeking its next generation of graduate students. These students are exposed to the undersold breadth of research on campus and given tremendous resources to lead their own impactful research.

Post attachment
Brian J. Abraham avatar
Brian J. Abraham@TheAbraLab·14 Oct 2022

Our massive undertaking in finding vulnerabilities of pediatric cancers requires massive #bioinformatics talent. I'm excited to be a part of the team and am looking for scientists to join the effort. Posting forthcoming, but feel free to email your CV.

"Through #PedDep, we believe we can leapfrog barriers to rapidly identify therapeutic vulnerabilities in childhood cancer and translate those into targeted therapies in the clinic faster," says project co-lead Dr. Charles Roberts, St. Jude Comprehensive Cancer Center director.

Adam Durbin avatar
⟳ Brian J. Abraham retweeted
Adam Durbin@ADurbinLab·17 May 2022

Pleased that our review on cell state plasticity and core regulatory circuitry online! Check it out! Thanks to @CellRepMed, including @isabelgoldm and @DrSaraHam for their support!. @TheAbraLab @markw_zimmerman. #neuroblastoma #epigenetics cell.com/cell-reports-medici…

Brian J. Abraham avatar
Brian J. Abraham@TheAbraLab·23 Feb 2022

Analyzing sequencing data can be hard, especially if you don't have a seasoned analyst or heavy-duty hardware. So @Modupeore_A built a portable, modular, automated, cloud (and more) pipeline to do the most common ChIP-Seq/CUT&RUN-Seq analyses for about $20 per sample.

St. Jude coders built a portable, one-click platform called SEAseq to streamline analysis of chromatin pulldown sequencing data (ChIP-Seq and CUT&RUN-Seq). Read the @BMC_series Bioinformatics Paper to learn how. ow.ly/TcCM50I2pKI @TheAbraLab

Post attachment
Brian J. Abraham avatar
Brian J. Abraham@TheAbraLab·25 Nov 2021

Deeply #thankful for strong, clever collaborators who like to tackle important problems, like this team. It made and makes sense for transcription factors that drive specific cancer types to be expressed only in those cancer types. @lawrensonlab built a way to find them.

This tweet is unavailable

Paul Geeleher avatar
⟳ Brian J. Abraham retweeted
Paul Geeleher@PGeeleher·9 Nov 2021

New paper out from our lab investigating the use of the putative RNA-POL I inhibitor CX-5461 in pediatric neuroblastoma. I believe this study represents a fantastic example of why the details of drug mechanism are deeply important for patient safety. nature.com/articles/s41467-0…

St. Jude Research avatar
⟳ Brian J. Abraham retweeted
St. Jude Research@StJudeResearch·22 Jan 2021

Join us for our first “The Science of Childhood Cancer” virtual lecture as Dr. Jinghui Zhang of St. Jude speaks on “Genomic Variants in Pediatric Cancer: Landscape, Precision Oncology, and Data Sharing Ecosystem” Thurs, Jan 28 at noon CT/5 pm CMT. ow.ly/8vBW50DfTO7 #SOCC21

Post attachment